Literature DB >> 6262390

Conditioned increases in locomotor activity produced with morphine as an unconditioned stimulus, and the relation of conditioning to acute morphine effect and tolerance.

R F Mucha, C Volkovskis, H Kalant.   

Abstract

Rats administered 5 mg/kg morphine SO4, through subcutaneously implanted catheters, during each of several daily sessions in an open field showed a progressive increase in locomotor activity measured in the open field prior to each morphine administration. Since the increases in activity were not observed in rats given morphine in a different environment (home cage) and saline in the open field, it is concluded that the increases were due to conditioning. In addition, the increases in activity were retained over a 7-day rest period; they were also produced when a second opiate (5 microgram/kg etorphine HCl) was substituted for morphine, were not seen when 2 mg/kg naloxone HCl (ip) was administered during treatment, and were present in rats showing tolerance to opiate-produced hypoactivity. Morphine's direct effect on activity is believed to have a biphasic dose-response curve; therefore, the relation of dose to conditioning was also studied. Increases in activity were the only conditioned behaviors observed; they were present only at the higher doses (16, 4, and 1 vs. .25, .065, and 0 mg/kg), and they occurred whether or not the dose was associated with unconditioned hypoactivity. The discussion deals with the relation of conditioning and morphine tolerance, the question of whether the unconditioned stimulus of morphine conditioning is a compensatory or a direct effect of morphine, and the similarity of conditioned increases in activity produced by morphine and by other stimuli that are reinforcing.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262390     DOI: 10.1037/h0077778

Source DB:  PubMed          Journal:  J Comp Physiol Psychol        ISSN: 0021-9940


  12 in total

1.  Conditioned tolerance in human opiate addicts.

Authors:  R Ehrman; J Ternes; C P O'Brien; A T McLellan
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Expression of morphine-conditioned hyperactivity is attenuated by naloxone and pimozide.

Authors:  J L Neisewander; M T Bardo
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  What is learned during opiate withdrawal conditioning? Evidence for a cue avoidance model.

Authors:  R F Mucha
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Associative factors in the effects of morphine on self-stimulation.

Authors:  T H Hand; K B Franklin
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Restrained rats learn amphetamine-conditioned locomotion, but not place preference.

Authors:  N R Swerdlow; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination.

Authors:  R F Mucha; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats.

Authors:  Ewa Galaj; Monica Manuszak; Sandra Babic; Subramaniam Ananthan; Robert Ranaldi
Journal:  Drug Alcohol Depend       Date:  2015-09-25       Impact factor: 4.492

8.  Conditioning of morphine-induced locomotor activity and stereotyped behaviour in rats.

Authors:  S Walter; K Kuschinsky
Journal:  J Neural Transm Gen Sect       Date:  1989

9.  Smoking stimuli from the terminal phase of cigarette consumption may not be cues for smoking in healthy smokers.

Authors:  Ronald F Mucha; Paul Pauli; Markus Weber; Markus Winkler
Journal:  Psychopharmacology (Berl)       Date:  2008-08-15       Impact factor: 4.530

10.  Scopolamine produces environment-specific conditioned activity that is not blocked by pimozide in rats.

Authors:  E J Mazurski; R J Beninger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.